Dr. Reddy's Laboratories announced the launch of Desmopressin Acetate Injection USP, 4 mcg/mL Single-dose Ampules, a therapeutic equivalent generic version of DDAVP (desmopressin acetate) Injection , 4 mcg/mL, approved by the U.S. Food and Drug Administration (USFDA).
The DDAVP (desmopressin acetate) Injection USP brand and generic market had U.S. sales of approximately $20.9 million MAT for the most recent twelve months ending in March 2020 according to IQVIA Health.
Dr. Reddy's Desmopressin Acetate Injection USP, 4 mcg/mL is available in a carton of ten 1 mL singledose ampules.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
